Visiongain publishes Constipation Nutraceuticals Market Report 2020-2030

01 June 2020
Pharma

Visiongain has launched a new report Constipation Nutraceuticals Market Report 2020-2030: Forecasts by Segment (Fibers & Specialty Carbohydrates, Vitamins, Minerals, Carotenoids, Omega-3 Fatty Acids, Prebiotics & Probiotics, Amino Acids & Proteins, Others); by Form (Dry Form and Liquid Form). Plus Financial Analysis of Leading Companies and Regional and Leading National Market Analysis.

Visiongain has forecasted that the global constipation nutraceuticals market will see a revenue of $xyz billion in 2020. Nutraceuticals are the products that provide medicinal and health benefits to the people. These products provide additional nutritional value to the foodstuff. Since 1990’s, there has been a considerable shift in the preference among the consumers towards consumption of nutraceuticals. Presently, the population segment prefers consumption of nutraceuticals as they help to reduce the expensive and high-tech disease treatment. Constipation Nutraceuticals are primarily used in dietary supplements, functional food and beverages as they have natural properties that are essential for disease prevention, and health promotion. Currently, majority of the population segment are aware about their health and believe that proper intake of nutrition can prevent the occurrence of chronic diseases. Nutraceuticals are not only consumed to maintain the dietary allowance but to enhance the performance and prevent diseases. Thus, nutraceuticals as a term is referred to food and food products that after consumption can provide incremental health benefits.

To access the data contained in this document please email contactus@visiongain.com

The global constipation nutraceuticals market is rising majorly due to increasing geriatric population, rising prevalence of chronic diseases, growing obese population and increasing health awareness. However, high cost of the products and availability of the products are some of the factors that might restrict the growth of the market to some extent during the study period.

On the basis of segment, fibers & specialty carbohydrates segment dominated the global constipation nutraceuticals market in 2020. The dominance of this market segment was majorly due to increasing preference among the population for healthy and nutritional food. Prebiotics and probiotics market segment is estimated to be the most lucrative market during the forecast period from 2020-2030. The growth in this market segment was majorly due to advantages of these products on gut health and increasing application areas, collectively all these factors support the future growth of the prebiotics and probiotics market segment during the study period.

On the basis of form, the dry form segment is expected to dominated the global constipation nutraceuticals market. The dominance of this market segment was majorly due to preference among the companies for this form as its helps to maintain the moisture and nutrient value in the products. In addition, it also retains the shelf life of the product.

Geographically, Asia-Pacific region accounted for the largest market share owing to rising demand for healthy and nutritional products, increasing awareness, rising disposable income and changing lifestyle. In addition, increasing population base and rising demand also support the growth of the regional market during the forecast period.

Companies Profiled:
• DuPont de Nemours, Inc.
• Glanbia Plc
• DSM
• Associated British Foods, Plc
• Ingredion Incorporated
• Tate & Lyle
• Ajinomoto Group
• BASF SE
• Kerry Group
• Cargill, Inc.
• ADM
• Arla Foods
• Chr. Hansen Holding A/S

Visiongain's global constipation nutraceuticals market report can keep you informed and up to date with the developments in the market, across four different regions: North America, Europe, Asia-Pacific, South America and Middle-East & Africa.

With reference to this report, it details the key investments trend in the global market, subdivided by segment, by form and by regions. Through extensive secondary research and interviews with industry experts, Visiongain has identified a series of market trends that will impact the constipation nutraceuticals market over the forecast timeframe.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever